Pharmacy bodies warn that demand for weight-loss drug will outstrip supply

Pharmacy bodies have warned that demand for the weight-loss drug tirzepatide (Mounjaro: Eli Lilly) — which can now be prescribed by GPs — will exceed supply. In statements given to The Pharmaceutical Journal, pharmacy bodies added that pharmacies could offer support services to patients newly prescribed the drug. Mounjaro became eligible for primary care prescription […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.361932
Primary Topic: Health Services Management and Policy
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Pharmacy bodies warn that demand for weight-loss drug will outstrip supply

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Health Services Management and Policy

article

Pharmacy bodies warn that demand for weight-loss drug will outstrip supply

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 76%

Health Services Management and Policy

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacy bodies warn that demand for weight-loss drug will outstrip supply · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS